Bemiparin Versus Enoxaparin as Thromboprophylaxis Following Vaginal and Abdominal Deliveries: A Prospective Clinical Trial View Homepage


Ontology type: schema:MedicalStudy     


Clinical Trial Info

YEARS

2012-2013

ABSTRACT

The use of a new generation low molecular weight heparin (Bemiparin)and the well known LMWH (Enoxaparin) after Caesarean sections and vaginal deliveries in a risky group patients for venous thrombosis. Detailed Description Venous thromboembolism (VTE) is the leading cause of maternal mortality and morbidity in the developed and developing world. Pulmonary embolism and deep vein thrombosis are the two components of a single disease called deep vein thrombosis (DVT). Pregnancy associated with an average 5 to 10 fold increase in the risk of VTE compared with non-pregnant women. The highest incidence occurring during the post partum period. There are many researches done a broad on the effect of LMWH to decrease the incidence of VTE after Caesarean section using the two LMWH (Enoxaparin and Bemiparin) alone but not in one research comparing both of them alone and both together against a control group. Also according to our knowledge there are no published literature on thromboprophylaxis after vaginal delivery More... »

URL

https://clinicaltrials.gov/show/NCT01588171

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3048", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "description": "The use of a new generation low molecular weight heparin (Bemiparin)and the well known LMWH (Enoxaparin) after Caesarean sections and vaginal deliveries in a risky group patients for venous thrombosis.\n\nDetailed Description\nVenous thromboembolism (VTE) is the leading cause of maternal mortality and morbidity in the developed and developing world. Pulmonary embolism and deep vein thrombosis are the two components of a single disease called deep vein thrombosis (DVT). Pregnancy associated with an average 5 to 10 fold increase in the risk of VTE compared with non-pregnant women. The highest incidence occurring during the post partum period. There are many researches done a broad on the effect of LMWH to decrease the incidence of VTE after Caesarean section using the two LMWH (Enoxaparin and Bemiparin) alone but not in one research comparing both of them alone and both together against a control group. Also according to our knowledge there are no published literature on thromboprophylaxis after vaginal delivery", 
    "endDate": "2013-11-01T00:00:00Z", 
    "id": "sg:clinicaltrial.NCT01588171", 
    "keywords": [
      "AS", 
      "delivery", 
      "prospective clinical trial", 
      "Low-Molecular-Weight Heparin", 
      "Cesarean Section", 
      "vaginal delivery", 
      "patient", 
      "Venous Thrombosis", 
      "venous thromboembolism", 
      "VTE", 
      "maternal mortality", 
      "morbidity", 
      "world", 
      "pulmonary embolism", 
      "component", 
      "pregnancy", 
      "fold increase", 
      "risk", 
      "non-pregnant woman", 
      "high incidence", 
      "period", 
      "decrease", 
      "incidence", 
      "caesarean", 
      "section", 
      "control group", 
      "published literature"
    ], 
    "name": "Bemiparin Versus Enoxaparin as Thromboprophylaxis Following Vaginal and Abdominal Deliveries: A Prospective Clinical Trial", 
    "sameAs": [
      "https://app.dimensions.ai/details/clinical_trial/NCT01588171"
    ], 
    "sdDataset": "clinical_trials", 
    "sdDatePublished": "2019-03-07T15:24", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "file:///pack/app/us_ct_data_00012.json", 
    "sponsor": [
      {
        "id": "https://www.grid.ac/institutes/grid.412012.4", 
        "type": "Organization"
      }
    ], 
    "startDate": "2012-05-01T00:00:00Z", 
    "subjectOf": [
      {
        "id": "sg:pub.10.1186/s12884-015-0515-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026592625", 
          "https://doi.org/10.1186/s12884-015-0515-2"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "type": "MedicalStudy", 
    "url": "https://clinicaltrials.gov/show/NCT01588171"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/clinicaltrial.NCT01588171'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/clinicaltrial.NCT01588171'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/clinicaltrial.NCT01588171'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/clinicaltrial.NCT01588171'


 

This table displays all metadata directly associated to this object as RDF triples.

50 TRIPLES      16 PREDICATES      43 URIs      36 LITERALS      1 BLANK NODES

Subject Predicate Object
1 sg:clinicaltrial.NCT01588171 schema:about anzsrc-for:3048
2 schema:description The use of a new generation low molecular weight heparin (Bemiparin)and the well known LMWH (Enoxaparin) after Caesarean sections and vaginal deliveries in a risky group patients for venous thrombosis. Detailed Description Venous thromboembolism (VTE) is the leading cause of maternal mortality and morbidity in the developed and developing world. Pulmonary embolism and deep vein thrombosis are the two components of a single disease called deep vein thrombosis (DVT). Pregnancy associated with an average 5 to 10 fold increase in the risk of VTE compared with non-pregnant women. The highest incidence occurring during the post partum period. There are many researches done a broad on the effect of LMWH to decrease the incidence of VTE after Caesarean section using the two LMWH (Enoxaparin and Bemiparin) alone but not in one research comparing both of them alone and both together against a control group. Also according to our knowledge there are no published literature on thromboprophylaxis after vaginal delivery
3 schema:endDate 2013-11-01T00:00:00Z
4 schema:keywords AS
5 Cesarean Section
6 Low-Molecular-Weight Heparin
7 VTE
8 Venous Thrombosis
9 caesarean
10 component
11 control group
12 decrease
13 delivery
14 fold increase
15 high incidence
16 incidence
17 maternal mortality
18 morbidity
19 non-pregnant woman
20 patient
21 period
22 pregnancy
23 prospective clinical trial
24 published literature
25 pulmonary embolism
26 risk
27 section
28 vaginal delivery
29 venous thromboembolism
30 world
31 schema:name Bemiparin Versus Enoxaparin as Thromboprophylaxis Following Vaginal and Abdominal Deliveries: A Prospective Clinical Trial
32 schema:sameAs https://app.dimensions.ai/details/clinical_trial/NCT01588171
33 schema:sdDatePublished 2019-03-07T15:24
34 schema:sdLicense https://scigraph.springernature.com/explorer/license/
35 schema:sdPublisher Nbb690322533e4f9ba7717bb21c25f0f2
36 schema:sponsor https://www.grid.ac/institutes/grid.412012.4
37 schema:startDate 2012-05-01T00:00:00Z
38 schema:subjectOf sg:pub.10.1186/s12884-015-0515-2
39 schema:url https://clinicaltrials.gov/show/NCT01588171
40 sgo:license sg:explorer/license/
41 sgo:sdDataset clinical_trials
42 rdf:type schema:MedicalStudy
43 Nbb690322533e4f9ba7717bb21c25f0f2 schema:name Springer Nature - SN SciGraph project
44 rdf:type schema:Organization
45 anzsrc-for:3048 schema:inDefinedTermSet anzsrc-for:
46 rdf:type schema:DefinedTerm
47 sg:pub.10.1186/s12884-015-0515-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026592625
48 https://doi.org/10.1186/s12884-015-0515-2
49 rdf:type schema:CreativeWork
50 https://www.grid.ac/institutes/grid.412012.4 schema:Organization
 




Preview window. Press ESC to close (or click here)


...